Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001596770-16-000112
Filing Date
2016-02-12
Accepted
2016-02-12 17:25:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 ZAFGEN SCHEDULE 13G/A 2-12-16 schedule13ga.htm SC 13G/A 152900
  Complete submission text file 0001596770-16-000112.txt   154486
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 161420899
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 415-362-4022
Alta Partners VIII, L.P. (Filed by) CIK: 0001399763 (see all company filings)

EIN.: 204774702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A